We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

I'm ok with this


We deliver tangible benefits to patients

Innovation is at the heart of everything we do. When developing medicines, we work closely with all key stakeholders right from the start during the R&D process. Why? To ensure that we deliver the best solutions with the highest possible benefits for patients.

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiologies, understanding of the patient, the use of available data and state-of-the-art devices and technologies that result in innovative solutions for the patients need. These attributes are the driving force behind our new ideas and future therapies.

This is what we do

Our focus

The treatment of pain is our key focus. As a worldwide leader in pain for over 40 years, we are fully aware that patients in this area are still hugely underserved. Not only are we dedicated to providing solutions to relieve the symptoms of pain, but we are also transforming the field to solve pain. Through our own research and through drawing on external innovation and collaborations, we are redefining and shaping the future of pain management. Patient Days and Patient Summits allow us to listen to the patient perspective to better understand their experiences of living with a range of chronic pain conditions.

We have a deep understanding of the underlying disease and we are using that knowledge to explore disease modifying approaches. For example, our “pain landscape” – which identifies and details precise pain indications such as Complex Regional Pain Syndrome (CRPS) – is helping us to develop high-level innovations.

We understand how pivotal the combination of technology and medicines can be in driving innovation forward and are keen to explore how we can use devices and technologies to improve the lives of patients.

Our capabilities

Through our fully integrated R&D capabilities and networked approach, we combine the best of two worlds:

  • We discover and develop New Chemical Entities (NCEs) and new technologies in-house, using our own extensive experience and expertise
  • We search for and access external innovation and knowledge – and we are courageous in exploiting new paths. To access the vibrant biotech community in Boston, USA, for example, we have established an innovation hub in the area.

Drawing on our broad in-house capabilities across all aspects of R&D, we ensure that our medical solutions and innovations will be valued by the health authorities and make a real difference to the lives of patients.

Research collaborations

We are passionate about bringing true benefits to the lives of patients, so are continually looking for opportunities to innovate. We want to expand our R&D networks, access new assets and technologies (data and devices) and enrich our pipeline. ... Find out more about how we can work together to improve the lives of patients
External Link:
You are now leaving the Grünenthal (IE) website. You will be re-directed to an external website. Grünenthal Pharma Ltd., Ireland accepts no responsibility for the content of other websites. ... Cancel ... Ok